We are live on ! Find out more

359 hedge funds and large institutions have $13B invested in Incyte in 2016 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 138 increasing their positions, 128 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more call options, than puts

Call options by funds: $81.9M | Put options by funds: $38.6M

8% more repeat investments, than reductions

Existing positions increased: 138 | Existing positions reduced: 128

6% less funds holding

Funds holding: 381359 (-22)

27% less first-time investments, than exits

New positions opened: 53 | Existing positions closed: 73

31% less funds holding in top 10

Funds holding in top 10: 139 (-4)

32% less capital invested

Capital invested by funds: $18.9B → $13B (-$5.99B)

Holders
359
Holders Change
-22
Holders Change %
-5.77%
% of All Funds
9.53%
Holding in Top 10
9
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-30.77%
% of All Funds
0.24%
New
53
Increased
138
Reduced
128
Closed
73
Calls
$81.9M
Puts
$38.6M
Net Calls
+$43.2M
Net Calls Change
-$26.2M

INCY Hedge Fund Activity: Q1 2016 in Review

359 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Incyte (INCY) for Q1 2016, worth a combined $13B — down 32% from $18.9B a quarter earlier.

Sellers outnumbered buyers: 73 funds closed out of INCY and 53 opened new positions — a net loss of 20 holders — while 128 trimmed existing stakes and 138 added.

The largest buyer was Wellington Management Group, adding an estimated $923M. The largest seller was T. Rowe Price Associates, cutting an estimated $218M.

  • 359 institutional investors held Incyte (INCY) as of Q1 2016, down from 381 in Q4 2015.
  • Funds reported $13B of Incyte stock for Q1 2016, down 32% quarter-over-quarter.
  • 53 funds opened new Incyte positions in Q1 2016 and 73 closed out, a net change of -20 holders.
  • The largest Incyte buyer in Q1 2016 was Wellington Management Group, an estimated $923M added.
  • The largest Incyte seller in Q1 2016 was T. Rowe Price Associates, an estimated $218M sold.

Based on aggregated 13F filings for Q1 2016.